title: Effects of anti-TNF-alpha antibody infliximab in refractory entero-Behcet's disease.
authors.forename: Shigeru
authors.initials: S
authors.lastname: Iwata
authors.forename: Kazuyoshi
authors.initials: K
authors.lastname: Saito
authors.forename: Kunihiro
authors.initials: K
authors.lastname: Yamaoka
authors.forename: Shizuyo
authors.initials: S
authors.lastname: Tsujimura
authors.forename: Masao
authors.initials: M
authors.lastname: Nawata
authors.forename: Katsunori
authors.initials: K
authors.lastname: Suzuki
authors.forename: Yoshiya
authors.initials: Y
authors.lastname: Tanaka
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001528:Behcet Syndrome / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D000069285:Infliximab; D007410:Intestinal Diseases / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D055815:Young Adult
chemical_list: D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab